4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer

NCT00005047 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
521
Enrollment
NETWORK
Sponsor class

Stopped Accrual was halted on the basis of the Data and Safety Monitoring Board review of a futility analysis.

Conditions

Interventions

Sponsor

SWOG Cancer Research Network

Collaborators